{
    "ticker": "AVGR",
    "name": "Avinger, Inc.",
    "description": "Avinger, Inc. is a medical device company that is revolutionizing the treatment of peripheral artery disease (PAD). Founded in 2007 by Dr. John B. Simpson, a vascular surgeon, Avinger focuses on developing innovative, catheter-based technologies that enable physicians to treat PAD more effectively. The company's flagship product, the Lumivascular platform, combines advanced imaging technologies with therapeutic capabilities, allowing physicians to visualize and treat blockages in the arteries in real-time. Avinger's devices are designed to improve patient outcomes while reducing the risks associated with traditional vascular interventions. The company's mission is to restore blood flow to patients suffering from PAD, enhancing their quality of life and minimizing the need for more invasive surgical procedures. With a commitment to continuous innovation, Avinger is actively investing in research and development to expand its product offerings and improve its existing solutions. Avinger is headquartered in Redwood City, California, and is publicly traded on the NASDAQ stock exchange under the ticker AVGR.",
    "industry": [
        "Medical Devices",
        "Healthcare"
    ],
    "headquarters": "Redwood City, California, USA",
    "founded": "2007",
    "website": "https://www.avinger.com",
    "ceo": "Jeffrey Soergel",
    "social_media": {
        "twitter": "https://twitter.com/avingerinc",
        "linkedin": "https://www.linkedin.com/company/avinger"
    },
    "investor_relations": "https://investors.avinger.com",
    "key_executives": [
        {
            "name": "Jeffrey Soergel",
            "position": "CEO"
        },
        {
            "name": "David E. C. K. H. Hsu",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Vascular Devices",
            "products": [
                "Lumivascular System"
            ]
        }
    ],
    "seo": {
        "meta_title": "Avinger, Inc. | Innovative Solutions for Peripheral Artery Disease",
        "meta_description": "Explore Avinger, Inc., a leader in the development of advanced medical devices for treating peripheral artery disease. Learn about our innovative Lumivascular platform and commitment to improving patient outcomes.",
        "keywords": [
            "Avinger",
            "Peripheral Artery Disease",
            "Medical Devices",
            "Lumivascular",
            "Healthcare Innovation"
        ]
    },
    "faq": [
        {
            "question": "What does Avinger specialize in?",
            "answer": "Avinger specializes in developing innovative medical devices for the treatment of peripheral artery disease."
        },
        {
            "question": "Who is the CEO of Avinger?",
            "answer": "Jeffrey Soergel is the CEO of Avinger, Inc."
        },
        {
            "question": "Where is Avinger headquartered?",
            "answer": "Avinger is headquartered in Redwood City, California, USA."
        },
        {
            "question": "What are Avinger's main products?",
            "answer": "Avinger's main product is the Lumivascular System, which is used for treating blockages in arteries."
        },
        {
            "question": "When was Avinger founded?",
            "answer": "Avinger was founded in 2007."
        }
    ],
    "competitors": [
        "BDX",
        "ISRG",
        "SYK"
    ],
    "related_stocks": [
        "JNJ",
        "ABT",
        "MDT",
        "ZBH"
    ]
}